Could a diabetes drug and a craving blocker tame alcohol addiction?
NCT ID NCT07249554
First seen Dec 12, 2025 · Last updated May 16, 2026 · Updated 12 times
Summary
This early-stage study tests whether combining semaglutide (a diabetes drug) with naltrexone (a craving-reducing medication) can safely help people with alcohol use disorder drink less. About 45 adults in a residential treatment program will take the combo for 4 weeks. Researchers will track side effects and changes in drinking behavior to see if the approach is promising.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Ashley Addiction Treatment
Havre de Grace, Maryland, 21078, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.